A 58-year-old man from Delhi presents with fever, cough, and dyspnea on day 5 of illness. RT-PCR for SARS-CoV-2 is negative, but CT chest shows bilateral ground-glass opacities. Which virological feature of SARS-CoV-2 best explains the delayed or false-negative RT-PCR result compared to influenza A?

Explanation

## Virological Basis of False-Negative SARS-CoV-2 RT-PCR **Key Point:** SARS-CoV-2 exhibits slower replication kinetics and preferentially infects the lower respiratory tract, resulting in lower viral loads in nasopharyngeal swabs compared to influenza A, which replicates rapidly in the upper respiratory tract. ### Viral Replication Kinetics Comparison | Parameter | SARS-CoV-2 | Influenza A | |-----------|-----------|-------------| | Primary replication site | Lower respiratory tract (lungs) | Upper respiratory tract (nasopharynx) | | Viral load peak timing | Day 5–7 of illness | Day 2–3 of illness | | Nasopharyngeal viral load | Lower (especially after day 5) | Higher throughout acute phase | | Replication rate | Slower | Rapid | | False-negative RT-PCR risk | Higher (especially mid-late illness) | Lower | **High-Yield:** SARS-CoV-2 preferentially replicates in the lower respiratory tract (alveolar epithelium), whereas influenza A replicates in the upper respiratory tract. This anatomical preference explains why nasopharyngeal swabs may be negative despite active lower respiratory infection. ### Clinical Implications 1. **Timing of testing:** RT-PCR sensitivity is highest in the first 5 days; sensitivity drops significantly after day 7–10. 2. **Specimen type matters:** Lower respiratory tract specimens (sputum, bronchoalveolar lavage) have higher sensitivity than nasopharyngeal swabs in late-stage disease. 3. **CT findings persist longer:** Radiological changes (ground-glass opacities) may persist despite negative RT-PCR, reflecting viral-induced inflammation rather than active replication. **Clinical Pearl:** In a patient with clinical and radiological evidence of COVID-19 but negative RT-PCR on day 5, consider repeat testing with a lower respiratory specimen (sputum or BAL) or serological testing for antibodies. This scenario is common and does not exclude SARS-CoV-2 infection. **Mnemonic:** **LRTS** — Lower Respiratory Tract Site (SARS-CoV-2 preference) vs **URTS** — Upper Respiratory Tract Site (Influenza preference). [cite:Harrison 21e Ch 197; Robbins 10e Ch 8]